{
  "label": "q_cs03_q04_action",
  "artifact_type": "question",
  "artifact_id": "sha256:59b05d8c4d7846cd8cb0ebe68cb63c4335bef1c524744ff59e8fbc34eb91a375",
  "input_ids": [
    "sha256:b4ba5337b06c8de68ac3315db1a4f6980c5bd48efd529c3914f30297d6afd329",
    "sha256:526bf0877b15ba594954d8544c6493f2535bc8acb2239824a0eeeb941d801b2d",
    "sha256:ace01eb11bd178d41631a87820db3d0b38695724566df0e4cf754bd0d2a63a06",
    "sha256:c8ec2a7b2e60743df8c142a1fb947c03f41df6d1885fabc02216a0cc7a001b94"
  ],
  "prompt_id": null,
  "model_config": null,
  "created_at": "2026-02-17T12:01:44.859837",
  "content": "{\n  \"question_id\": \"cs03_q04_action\",\n  \"scope_id\": \"clinical_signal_03\",\n  \"checkpoint_after\": 30,\n  \"question_type\": \"action_recommendation\",\n  \"prompt\": \"What protocol amendments should the DSMB recommend?\",\n  \"ground_truth\": {\n    \"canonical_answer\": \"Exclude concomitant statin use from the trial. Add CYP3A4 interaction screening. Implement more frequent hepatic panel monitoring for enrolled subjects. Consider dose adjustment studies for the LNS-4821/statin interaction.\",\n    \"required_evidence_refs\": [\n      \"clinical_signal_03_ep_019\",\n      \"clinical_signal_03_ep_023\",\n      \"clinical_signal_03_ep_026\"\n    ],\n    \"key_facts\": [\n      \"the hepatic enzyme pattern is consistent with a drug-drug interaction mediated through shared hepatic metabolism pathways, not direct hepatotoxicity\",\n      \"ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases\",\n      \"musculoskeletal safety endpoints track within expected ranges, confirming the safety signal is organ-specific to the liver\"\n    ]\n  }\n}",
  "metadata": {
    "question_id": "cs03_q04_action",
    "question_type": "action_recommendation",
    "checkpoint_after": 30,
    "scope_id": "clinical_signal_03",
    "layer_name": "questions",
    "layer_level": 3,
    "build_fingerprint": {
      "scheme": "synix:build:v1",
      "digest": "cea407b77119c15202fd5fd20b9a0dab1dc93ea29aec8fe4a5d92cddd0ccf174",
      "components": {
        "transform": "a7d463dc476b419c96a5f454f481b455ca81a8d8ee3904631b7729963317406f",
        "inputs": "fe47a7d9fa60fa84"
      }
    },
    "transform_fingerprint": {
      "scheme": "synix:transform:v2",
      "digest": "a7d463dc476b419c96a5f454f481b455ca81a8d8ee3904631b7729963317406f",
      "components": {
        "transform_id": "3176c030aaa3a69e",
        "source": "929fe273ac2dab06",
        "model": "1e2ccf75e96d7ee7"
      }
    }
  }
}